当前位置: 首页 > 详情页

Rab-mediated endocytosis - Linking neurodegeneration, neuroprotection, and synaptic plasticity?

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE ◇ CPCI(ISTP)

机构: [a]Memory Disorders Program, VA HCS Long Beach, Long Beach, California, USA [b]Southern California Institute for Research and Education (SCIRE), Long Beach, California, USA [c]Psychiatry and Human Behavior, University of California at Irvine, Irvine, California, USA [d]Present address: Department of Developmental Neurobiology, St. Jude Children’s Research Hospital, Memphis, Tennessee, USA. [e]Experimental Center, Xuan-wu Hospital of Capital Medical University, Key Laboratory for Neurodegenerative Diseases of Ministry of Education, Beijing, China [f]Present address: Experimental Center, Xuan-wu Hospital of Capital Medical University, Key Laboratory for Neurodegenerative Diseases of Ministry of Education, Beijing, China.
出处:
ISSN:

关键词: DHPG GTPase metabotropic LTD Rab5b

摘要:
Rab proteins are small GTPases involved in endocytosis and recycling of cell surface molecules. Recently they have been implicated in the etiopathogenesis of several neurodegenerative disorders including Alzheimer's and Lewy body disease. In experiments on organotypic hippocampal cultures, upregulation of Rab protein family member Rab5b after group I metabotropic glutamate receptor (mGluR) stimulation was associated with reduced neuronal vulnerability to excitotoxic injury. This mGluR-mediated neuroprotection was abolished by antisense-induced deficiency of Rab5b. Electrophysiological measurements of excitatory synaptic transmission in the Schaffer collateral-CA1 pathway revealed that mGluR activation that induces neuroprotection also induced long-term depression (LTD) of synaptic transmission. Similar to the neuroprotection, Rab5b deficiency abolished dihydroxyphenylglycine-induced LTD. Together, these findings support the idea that Rab proteins, and the Rab5b protein in particular, may provide a link between neurodegenerative disease, neuroprotection, and synaptic plasticity, as well as possibly being a useful target for pharmacological interventions.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2006]版:
大类 | 3 区 综合性期刊
最新[2023]版:
大类 | 3 区 综合性期刊
小类 | 3 区 综合性期刊
JCR分区:
出版当年[2005]版:
Q1 MULTIDISCIPLINARY SCIENCES
最新[2023]版:
Q1 MULTIDISCIPLINARY SCIENCES

影响因子: 最新[2023版] 最新五年平均 出版当年[2005版] 出版当年五年平均 出版前一年[2004版] 出版后一年[2006版]

第一作者:
第一作者机构: [a]Memory Disorders Program, VA HCS Long Beach, Long Beach, California, USA [b]Southern California Institute for Research and Education (SCIRE), Long Beach, California, USA [c]Psychiatry and Human Behavior, University of California at Irvine, Irvine, California, USA [*]Memory Disorders Program, VA HCS Long Beach, 5901 E. 7th St. 06/116 A, Long Beach, CA 90822.
通讯作者:
通讯机构: [*]Memory Disorders Program, VA HCS Long Beach, 5901 E. 7th St. 06/116 A, Long Beach, CA 90822.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:16409 今日访问量:0 总访问量:869 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院